LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 207

Search options

  1. Book ; Online: Myeloid Derived Suppressor Cells as Disease Modulators

    Finn, Olivera J. / Ochoa, Augusto C.

    2020  

    Keywords Medicine ; Immunology ; myeloid-derived suppressor cells (MDSC) ; cancer ; immunosuppression ; arginase 1 (Arg-1) ; chronic inflammatory diseases
    Size 1 electronic resource (162 pages)
    Publisher Frontiers Media SA
    Document type Book ; Online
    Note English ; Open Access
    HBZ-ID HT021230193
    ISBN 9782889636778 ; 2889636771
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  2. Book ; Conference proceedings: The renaissance of cancer immunotherapy

    Finn, Olivera J. / Schuler, Gerold

    the 7th International Cancer Vaccine Symposium [September 9 - 11, 2012, in Florence, Italy]

    (Annals of the new York Academy of Sciences ; 1284)

    2013  

    Event/congress International Cancer Vaccine Symposium (7, 2012, Florenz)
    Author's details issue ed. Olivera J. Finn and Gerold Schuler
    Series title Annals of the new York Academy of Sciences ; 1284
    Annals of the New York Academy of Sciences
    Collection Annals of the New York Academy of Sciences
    Language English
    Size VII, 86 S. : Ill., graph. Darst.
    Publisher Wiley
    Publishing place Hoboken, NJ
    Publishing country United States
    Document type Book ; Conference proceedings
    HBZ-ID HT017680142
    ISBN 978-1-57331-895-2 ; 1-57331-895-7
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Book: Tumor immunology

    Finn, Olivera J.

    (Immunological reviews ; 222)

    2008  

    Author's details Olivera J. Finn, guest ed
    Series title Immunological reviews ; 222
    Collection
    Language English
    Size 368 S. : Ill., graph. Darst.
    Publisher Blackwell Munksgaard
    Publishing place Oxford
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT015491148
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  4. Article ; Online: Introduction to the special issue: Tumor antigens in the time of the coronavirus pandemic.

    Finn, Olivera J

    Seminars in immunology

    2020  Volume 47, Page(s) 101396

    MeSH term(s) Animals ; Antigens, Neoplasm ; Betacoronavirus ; Biomarkers, Tumor/analysis ; COVID-19 ; Cancer Vaccines ; Coronavirus Infections ; Humans ; Immunotherapy ; Neoplasms/immunology ; Neoplasms/therapy ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2
    Chemical Substances Antigens, Neoplasm ; Biomarkers, Tumor ; Cancer Vaccines
    Keywords covid19
    Language English
    Publishing date 2020-04-03
    Publishing country England
    Document type Editorial ; Introductory Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1018141-6
    ISSN 1096-3618 ; 1044-5323
    ISSN (online) 1096-3618
    ISSN 1044-5323
    DOI 10.1016/j.smim.2020.101396
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Book ; Conference proceedings: Cellular immunity and immunotherapy of cancer

    Finn, Olivera J.

    [fourth meeting in the series of ... Keystone Symposia on Cellular Immunity and Immunotherapy of Cancer was held in January 2000 in Santa Fe, NM]

    (Clinical cancer research ; 7,3, Suppl.)

    2001  

    Event/congress Symposium on Cellular Immunity and the Immunotherapy of Cancer (4, 2000, SantaFeNM)
    Author's details guest-ed-in chief Olivera J. Finn
    Series title Clinical cancer research ; 7,3, Suppl.
    Collection
    Language English
    Size S. 759s - 989s : Ill., graph. Darst.
    Publisher American Association for Cancer Research
    Publishing place Philadelphia, PA
    Publishing country United States
    Document type Book ; Conference proceedings
    HBZ-ID HT012975892
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  6. Article ; Online: Editorial: Myeloid Derived Suppressor Cells as Disease Modulators.

    Finn, Olivera J / Ochoa, Augusto C

    Frontiers in immunology

    2020  Volume 11, Page(s) 90

    MeSH term(s) Animals ; Humans ; Myeloid-Derived Suppressor Cells
    Language English
    Publishing date 2020-01-31
    Publishing country Switzerland
    Document type Editorial ; Introductory Journal Article
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2020.00090
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A Believer's Overview of Cancer Immunosurveillance and Immunotherapy.

    Finn, Olivera J

    Journal of immunology (Baltimore, Md. : 1950)

    2018  Volume 200, Issue 2, Page(s) 385–391

    Abstract: The field of tumor immunology has grown around the idea that one of the important roles of the immune system is to eliminate cancer. This idea was difficult to reconcile with the accepted notion that the immune system evolved to distinguish self from ... ...

    Abstract The field of tumor immunology has grown around the idea that one of the important roles of the immune system is to eliminate cancer. This idea was difficult to reconcile with the accepted notion that the immune system evolved to distinguish self from nonself and therefore tumors derived from self-tissues would not be recognized. Lack of appropriate animal models prevented experimental testing of cancer immunosurveillance. This changed with the realization that the immune system evolved to recognize danger and with the advent of mouse models deficient in one or more immune function, which showed predicted increases in susceptibility to cancer. Simultaneously, technical advances that enabled the study of the human immune system provided data for the existence of tumor-specific T cells and Abs and led to molecular identification of tumor Ags, fully validating the cancer immunosurveillance hypothesis. Immunotherapy designed to strengthen cancer immunosurveillance has achieved unprecedented clinical successes.
    MeSH term(s) Animals ; Antigens, Neoplasm/immunology ; Humans ; Immune System/cytology ; Immune System/immunology ; Immune System/metabolism ; Immunologic Surveillance ; Immunotherapy/methods ; Neoplasms/immunology ; Neoplasms/therapy
    Chemical Substances Antigens, Neoplasm
    Language English
    Publishing date 2018-01-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 3056-9
    ISSN 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
    ISSN (online) 1550-6606
    ISSN 0022-1767 ; 1048-3233 ; 1047-7381
    DOI 10.4049/jimmunol.1701302
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Advances and challenges in cancer immunoprevention and immune interception.

    Stanton, Sasha E / Castle, Philip E / Finn, Olivera J / Sei, Shizuko / Emens, Leisha A

    Journal for immunotherapy of cancer

    2024  Volume 12, Issue 3

    Abstract: Invasive cancers typically evade immune surveillance through profound local and systemic immunosuppression, preventing their elimination or control. Targeting immune interventions to prevent or intercept premalignant lesions, before significant immune ... ...

    Abstract Invasive cancers typically evade immune surveillance through profound local and systemic immunosuppression, preventing their elimination or control. Targeting immune interventions to prevent or intercept premalignant lesions, before significant immune dysregulation has occurred, may be a more successful strategy. The field of cancer immune interception and prevention is nascent, and the scientific community has been slow to embrace this potentially most rational approach to reducing the global burden of cancer. This may change due to recent promising advances in cancer immunoprevention including the use of vaccines for the prevention of viral cancers, the use of cancer-associated antigen vaccines in the setting of precancers, and the development of cancer-preventative vaccines for high-risk individuals who are healthy but carry cancer-associated heritable genetic mutations. Furthermore, there is increasing recognition of the importance of cancer prevention and interception by national cancer organizations. The National Cancer Institute (NCI) recently released the National Cancer Plan, which includes cancer prevention among the top priorities of the institute. The NCI's Division of Cancer Prevention has been introducing new funding opportunities for scientists with an interest in the field of cancer prevention: The Cancer Prevention-Interception Targeted Agent Discovery Program and The Cancer Immunoprevention Network. Moreover, the Human Tumor Atlas Network is spearheading the development of a precancer atlas to better understand the biology of pre-invasive changes, including the tissue microenvironment and the underlying genetics that drive carcinogenesis. These data will inform the development of novel immunoprevention/immuno-interception strategies. International cancer foundations have also started recognizing immunoprevention and immune interception with the American Association for Cancer Research, Cancer Research UK and the Society for Immunotherapy of Cancer each implementing programming focused on this area. This review will present recent advances, opportunities, and challenges in the emerging field of cancer immune prevention and immune interception.
    MeSH term(s) Humans ; United States ; Cancer Vaccines ; Immunotherapy ; Neoplasms/prevention & control ; Mutation ; Tumor Microenvironment
    Chemical Substances Cancer Vaccines
    Language English
    Publishing date 2024-03-21
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2719863-7
    ISSN 2051-1426 ; 2051-1426
    ISSN (online) 2051-1426
    ISSN 2051-1426
    DOI 10.1136/jitc-2023-007815
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines.

    Çuburu, Nicolas / Finn, Olivera J / Van Der Burg, Sjoerd H

    Frontiers in immunology

    2022  Volume 13, Page(s) 924099

    MeSH term(s) Humans ; Immunotherapy ; Neoplasms, Glandular and Epithelial ; Precancerous Conditions ; Vaccines
    Chemical Substances Vaccines
    Language English
    Publishing date 2022-05-24
    Publishing country Switzerland
    Document type Editorial ; Comment
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2022.924099
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top